PET/CT imaging in management of concomitant Hodgkin lymphoma and tuberculosis – a problem solver tool

Publisher： John Wiley & Sons Inc

E-ISSN： 2050-0904|6|1|232-234

ISSN： 2050-0904

Source： Clinical Case Reports, Vol.6, Iss.1, 2018-01, pp. : 232-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Key Clinical MessageInfectious lymph nodes mimicking lymphoma is challenging for accurate staging. Although 18F‐FDG is a nonspecific tracer accumulating not only in tumor cells but also in inflammatory tissues, the metabolic features and uptake kinetics give valuable information: 18F‐FDG PET/CT appears as a useful problem solver tool in ambiguous situation.

Related content

Radioimmunotherapy: Potential as a Therapeutic Strategy in Non-Hodgkin's Lymphoma

By Wun T.   Kwon D.S.   Tuscano J.M.  

BioDrugs, Vol. 15, Iss. 3, 2001-03 ,pp. : 151-162 (12)

Adis International

Access to resources Recommend Favorite

A difficult diagnosis of Hodgkin lymphoma due to immune thrombocytopenia

By  

Clinical Case Reports, Vol. 3, Iss. 3, 2015-03 ,pp. : 179-182 (4)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Toward Personalized Immunotherapy for Non-Hodgkin Lymphoma: Targeting the Idiotypic Immunoglobulin

By Armstrong Anne C.   Cheadle Eleanor J.   Hawkins Robert E.  

BioDrugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 289-297 (9)

Adis International

Access to resources Recommend Favorite

The Role of Radioimmunotherapy with Yttrium-90 Ibritumomab Tiuxetan in the Treatment of Non-Hodgkin Lymphoma

By Cheson Bruce D.  

BioDrugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 309-322 (14)

Adis International

Access to resources Recommend Favorite

Spotlight on Rituximab in Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

By Cvetković Risto S.   Perry Caroline M.  

BioDrugs, Vol. 20, Iss. 4, 2006-01 ,pp. : 253-257 (5)

Adis International

Access to resources Recommend Favorite